High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$572K
$572,377
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Equity Compensation
2025-12-17
$35,469x4
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-17 | $35,469x4 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-17
$136,872x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-17 | $136,872x3 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-11-13
$215,038x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-11-13 | $215,038x3 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -78.4%
2025-11-13
$435,505x3
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -78.4%
|
2025-11-13 | $435,505x3 | S | Form 4 |